SELE and breast cancer: Previous studies have also demonstrated the E-selectin-dependence of binding interactions between commercially available breast cancer cell lines and human umbilical vein endothelial cells (HUVECs; Giavazzi et al., 1993; Narita et al., 1996; Julien et al., 2011; Shirure et al., 2011, 2012).